GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Jibeier Pharmaceutical Co Ltd (SHSE:688566) » Definitions » Interest Coverage

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Interest Coverage : 786.46 (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Jibeier Pharmaceutical Co Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Jiangsu Jibeier Pharmaceutical Co's Operating Income for the three months ended in Mar. 2025 was ¥56.6 Mil. Jiangsu Jibeier Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2025 was ¥-0.1 Mil. Jiangsu Jibeier Pharmaceutical Co's interest coverage for the quarter that ended in Mar. 2025 was 786.46. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Jiangsu Jibeier Pharmaceutical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Jiangsu Jibeier Pharmaceutical Co's Interest Coverage or its related term are showing as below:

SHSE:688566' s Interest Coverage Range Over the Past 10 Years
Min: 47   Med: 1040.83   Max: 2343.98
Current: 2037.85


SHSE:688566's Interest Coverage is ranked better than
94.5% of 655 companies
in the Drug Manufacturers industry
Industry Median: 11.83 vs SHSE:688566: 2037.85

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Jiangsu Jibeier Pharmaceutical Co Interest Coverage Historical Data

The historical data trend for Jiangsu Jibeier Pharmaceutical Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Jiangsu Jibeier Pharmaceutical Co Interest Coverage Chart

Jiangsu Jibeier Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage
Get a 7-Day Free Trial Premium Member Only 1,167.45 1,040.83 425.01 2,343.98 2,305.12

Jiangsu Jibeier Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,057.32 3,505.61 10,027.83 2,237.90 786.46

Competitive Comparison of Jiangsu Jibeier Pharmaceutical Co's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Jibeier Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Jibeier Pharmaceutical Co's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Jibeier Pharmaceutical Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Jiangsu Jibeier Pharmaceutical Co's Interest Coverage falls into.


;
;

Jiangsu Jibeier Pharmaceutical Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Jiangsu Jibeier Pharmaceutical Co's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, Jiangsu Jibeier Pharmaceutical Co's Interest Expense was ¥-0.1 Mil. Its Operating Income was ¥295.1 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥0.0 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2024 )/Interest Expense (A: Dec. 2024 )
=-1*295.055/-0.128
=2,305.12

Jiangsu Jibeier Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Here, for the three months ended in Mar. 2025, Jiangsu Jibeier Pharmaceutical Co's Interest Expense was ¥-0.1 Mil. Its Operating Income was ¥56.6 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥0.0 Mil.

Interest Coverage=-1* Operating Income (Q: Mar. 2025 )/Interest Expense (Q: Mar. 2025 )
=-1*56.625/-0.072
=786.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Jiangsu Jibeier Pharmaceutical Co  (SHSE:688566) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Jiangsu Jibeier Pharmaceutical Co Interest Coverage Related Terms

Thank you for viewing the detailed overview of Jiangsu Jibeier Pharmaceutical Co's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Jibeier Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
High-tech Industrial Development Zone, Jiangsu Province, Zhenjiang, CHN, 212000
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
Executives
Hu Tao Director
Wu Ying senior management
Zhang Chun Director
Zhao Suo Fu senior management
Li Hai Dao Core technical personnel
Di Jian Zhong senior management
Qin Xu Feng Core technical personnel
Wu Xiu Gen Core technical personnel
Yu Xin Jun Directors, senior managers
Li Zhao Guang Core technical personnel
Geng Zhong Yi Directors, senior managers, core technical personnel

Jiangsu Jibeier Pharmaceutical Co Headlines

No Headlines